Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
120,192,308
-
Total 13F shares
-
17,453,204
-
Share change
-
+3,381,288
-
Total reported value
-
$101,100,262
-
Price per share
-
$5.82
-
Number of holders
-
55
-
Value change
-
+$20,834,844
-
Number of buys
-
37
-
Number of sells
-
16
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q4 2019
As of 31 Dec 2019,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,453,204 shares.
The largest 10 holders included
Bratton Capital Management, L.P., Opaleye Management Inc., VANGUARD GROUP INC, Wildcat Capital Management, LLC, Bracebridge Capital, LLC, MILLENNIUM MANAGEMENT LLC, Eversept Partners, LP, JPMORGAN CHASE & CO, OXFORD ASSET MANAGEMENT LLP, and D. E. Shaw & Co., Inc..
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.